Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.
CONCLUSIONS: The data indicate that the SOL regimen is effective and moderately tolerated in Chinese patients with mCRC.
TRIAL REGISTRATION:
CLINICAL TRIAL INFORMATION: ChiCTR-TNRC-100000838.
PMID: 26739998 [PubMed - in process]
Source: Chinese Journal of Cancer - Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Clinical Trials | Colorectal Cancer | Eloxatin | Hematology | Oral Cancer | Study | Thrombocytopenia | Toxicology